Zhou, S., M. Deng, X. Bian, J. Shi, R. Liang, and M. Tao. “Synergistic Anti-Tumor Effects of Lenalidomide and Gefitinib by Upregulating ADRB2 and Inactivating the mTOR/PI3K/AKT Signaling Pathway in Lung Adenocarcinoma: Role of ADRB2 and mTOR/PI3K/AKT in LUAD”. Cellular and Molecular Biology, vol. 70, no. 2, Feb. 2024, pp. 120-7, doi:10.14715/cmb/2024.70.2.17.